| scholarly article | Q13442814 |
| P50 | author | Byung Ha Chung | Q85328052 |
| P2093 | author name string | Yang-Gyun Kim | |
| Dong-Jin Kim | |||
| Sang-Ho Lee | |||
| Yeong Hoon Kim | |||
| Jae Berm Park | |||
| Sung-Jig Lim | |||
| Hyung-In Yang | |||
| Jung-Woo Seo | |||
| Ju-Young Moon | |||
| Chan-Duck Kim | |||
| Jaeseok Yang | |||
| Kyoung Soo Kim | |||
| Jin Sug Kim | |||
| Kyung-Hwan Jeong | |||
| Se-Yun Kim | |||
| Haena Moon | |||
| Yu Ho Lee | |||
| Seon Hwa Park | |||
| P2860 | cites work | Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface | Q73652344 |
| Glomerular inflammation in renal allografts biopsies after the first year: cell types and relationship with antibody-mediated rejection and graft outcome | Q82267596 | ||
| Lipid lowering agents and the endothelium: an update after 4 years | Q82656338 | ||
| C4d deposits on erythrocytes (EC4d): a new biomarker of antibody-mediated rejection in kidney transplantation | Q84672316 | ||
| Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study | Q85209453 | ||
| Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartan | Q85949465 | ||
| Endocan--the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease | Q86591214 | ||
| Endocan Concentration in Patients With Primary Hypertension | Q89771019 | ||
| Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease | Q45415175 | ||
| Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM). | Q45898843 | ||
| Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy. | Q45966400 | ||
| Endocan, a new invasion and angiogenesis marker of pituitary adenomas. | Q46843616 | ||
| Association of Endocan, Ischemia-Modified Albumin, and hsCRP Levels With Endothelial Dysfunction in Type 2 Diabetes Mellitus | Q47367683 | ||
| Urinary exosomal viral microRNA as a marker of BK virus nephropathy in kidney transplant recipients. | Q47561986 | ||
| ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma. | Q47825139 | ||
| Serum Endocan correlated with stage of chronic kidney disease and deterioration in renal transplant recipients | Q48329390 | ||
| MiR-142-5p and miR-486-5p as biomarkers for early detection of chronic antibody-mediated rejection in kidney transplantation. | Q50237087 | ||
| Clinical and molecular significance of microvascular inflammation in transplant kidney biopsies. | Q50802039 | ||
| A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. | Q51432032 | ||
| Endocan elicits severe vascular inflammatory responses in vitro and in vivo. | Q51757444 | ||
| Evaluation of Microvascular Inflammation in ABO-Incompatible Kidney Transplantation. | Q53055740 | ||
| Detection on dynamic changes of endothelial cell specific molecule-1 in acute rejection after renal transplantation. | Q54309295 | ||
| Circulating endothelial cells as potential markers of the state of the endothelium in hemodialysis patients | Q61905255 | ||
| Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1 | Q24291650 | ||
| A new equation to estimate glomerular filtration rate | Q24651973 | ||
| Vascular endothelium as a target of immune response in renal transplant rejection | Q27024077 | ||
| OPTN/SRTR 2013 Annual Data Report: kidney | Q30886232 | ||
| Endocan expression and relationship with survival in human non-small cell lung cancer | Q34555793 | ||
| MicroRNA-181b regulates NF-κB-mediated vascular inflammation | Q36005391 | ||
| Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection | Q36223302 | ||
| Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. | Q36259829 | ||
| Antibody-mediated organ-allograft rejection | Q36263023 | ||
| Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection. | Q36677655 | ||
| A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion | Q36704453 | ||
| Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer | Q37012393 | ||
| Plasma endocan level and prognosis of immunoglobulin A nephropathy | Q37260183 | ||
| Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy | Q37660263 | ||
| Modifiers of complement activation for prevention of antibody-mediated injury to allografts | Q37890840 | ||
| Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis? | Q37894728 | ||
| Serum Endocan as a Predictive Marker for Decreased Urine Volume in Peritoneal Dialysis Patients. | Q38876082 | ||
| Clinicopathological correlation of endocan expression and survival in epithelial ovarian cancer | Q38984247 | ||
| Donor-Specific Antibodies in Kidney Transplant Recipients | Q39265221 | ||
| An Integrated View of Molecular Changes, Histopathology and Outcomes in Kidney Transplants | Q39829568 | ||
| Endocan expression and localization in human glioblastomas | Q39848718 | ||
| Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
| Endothelial cell-specific molecule-1/endocan: Diagnostic and prognostic value in patients suffering from severe sepsis and septic shock | Q40942121 | ||
| Inflammation-induced increases in plasma endocan levels are associated with endothelial dysfunction in humans in vivo | Q41559086 | ||
| Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant. | Q41573946 | ||
| A Critical Appraisal of Methods to Grade Transplant Glomerulitis in Renal Allograft Biopsies | Q42846833 | ||
| Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma | Q43183910 | ||
| Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure | Q43918875 | ||
| Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies. | Q44260404 | ||
| Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions | Q45342440 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1854 | |
| P577 | publication date | 2019-02-12 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Endocan as a marker of microvascular inflammation in kidney transplant recipients | |
| P478 | volume | 9 |
| Q94584920 | Gait speed and handgrip strength as predictors of all-cause mortality and cardiovascular events in hemodialysis patients | cites work | P2860 |
Search more.